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Marker assisted speed congenics technique is commonly used to facilitate backcrossing of mouse strains in nearly half the time it
normally takes otherwise. Traditionally, the technique is performed by analyzing PCR amplified regions of simple sequence length
polymorphism (SSLP) markers between the recipient and donor strains: offspring with the highest number of markers showing the
recipient genome across all chromosomes is chosen for the next generation. Although there are well-defined panels of SSLPmakers
established between certain pairs of mice strains, they are incomplete for most strains. The availability of well-established marker
sets for speed congenic screenswould enable the scientific community to transfermutations across strain backgrounds. In this study,
we tested the suitability of over 400 SSLPmarker sets among 10mouse strains commonly used for generating genetically engineered
models. The panel of markers presented here can readily identify the specified strains and will be quite useful in marker assisted
speed congenic screens.Moreover, unlike newer single nucleotide polymorphism (SNP) arraymethods which require sophisticated
equipment, the SSLP markers panel described here only uses PCR and agarose gel electrophoresis of amplified products; therefore
it can be performed in most research laboratories.
1. Introduction
In recent years, there has been a steady increase in the cre-
ation and use of genetically engineered mutant mice for use
in biomedical research. Frequently, the genetic background of
suchmice allows only specific experiments and themutations
have to be transferred to different genetic background(s)
to facilitate other kinds of experiments. There are many
examples where genetic background is shown to influence
the phenotype of a transgenic or knockout mouse line [1–12].
Traditionally however, mutant mice are generated using
strains that have shown exceptional performance in terms of
their suitability for production of transgenic or knockout
mice lines. For example, FVB strain and BDF1 strain mice are
most commonly used for transgenicmice production [13] and
ES (embryonic stem) cells derived from 129 inbred strains are
commonly used for knockout mice production. For technical
reasons, chimeras developed in knockout mice generation
will carry a mixed genetic background (e.g., 129 and B6)
adding further complexity to the analysis [14]. Furthermore,
ES cells derived from C57BL6/N inbred strain have been
used in mouse genetic resources such as KOMP (Knock-Out
Mouse Project) and EUCOMM (European Conditional
Mouse Mutagenesis) [15]. Also, particular strains of mice
seem to have better suitability for a specific research purpose.
In addition, mixed background strains between C57BL/6J
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Table 1
Strain Vendor, stock number Rationale
C57BL/6J JaxMice, 000664 Commonly used strain in biomedical research
FVB/NJ JaxMice, 001800 Commonly used strain for transgenic mice generation
129 X1/SvJ JaxMice, 000691 Strains from which highly successful germ line transmission competent ES
cells were derived129S2 Charles River, 476
DBA2/J JaxMice, 000671
Together with C57BL6, these strains are used as hybrid strains for
transgenic mouse productionCBA/J JaxMice, 000656
SJL/J JaxMice, 000686
Balb/c Charles River, 028 Is among the top 2-3 most widely used inbred strains
C3H/HeJ Charles River 025 Used in a variety of research areas including cancer, infectious disease, and
cardiovascular biologyNOD Charles River
andDBA/2J were used for ENUmutagenesis projects because
the cross between two different inbred strains (one strain
(male) was used for ENU exposure and mated with another
strain (female)) is useful for mapping and positional cloning
of the mutated gene using genetic polymorphisms existing
between them [16, 17]. The main disadvantage of a given
mutation under a particular strain background is that the
strain background may limit its use for a specific research
purpose. In such a situation the mutation is needed to be
transferred into a strain background of choice through a
process called backcrossing.
Backcrossing involves about 10 generations of successive
breeding into a recipient strain of choice to achieve 99.9%
congenic (genetic composition) for that strain (http://www
.informatics.jax.org/silverbook/). This painstaking process
consumes about 2.5 to 3 years of time, a fact that often limits
its feasibility and usefulness given the pace of scientific
research. In some cases, studies are published with animals
after only 5 generations of backcrossing, in an attempt to
compensate the time required and the need to obtain some
results in the new strain [18]. A technique called “marker
assisted speed congenic” used for over a decade helps in
achieving congenic strain in 5 or less, unlike the usual 10
generations required in traditional backcrossing [19, 20]. The
small sequence differences between mouse strains called
“microsatellite markers” served as useful tools in detecting
the chromosome regions of origin in the offspring when two
inbred strains ofmice are bred together. To use in these assays,
manymicrosatellitemarkers have been identified and charac-
terized by various researchers between the donor and recipi-
ent strains of their choice ([21] and [22, page 6] and [23–30]).
However, the information about the markers that can differ-
entiate between commonly used strains for transgenic and
knockout mice generation is not tested sufficiently and is not
available readily. In this study, we tested 423 markers, ∼10
to 30 per chromosome, using the genomic DNAs from 10
commonly usedmice strains—particularly the strains used in
transgenic and knockout research. We evaluated the markers
that could be used in the agarose gel electrophoresis method
which is a simple technique commonly used in most molec-
ular biology laboratories these days. The data presented here
will serve as a valuable tool for various investigators in choos-
ing the markers useful for their speed congenic breeding.
2. Materials and Methods
2.1. Selection of Oligonucleotide Primers. The primers were
chosen based on the following criteria: (1) evaluation and esta-
blishment of at least 6 markers per chromosome, (2) distance
between the adjacent markers kept as minimum as 10 to 15
centimorgans (cM), and (3) polymorphic bands appreciable
when analyzed in a 4% agarose gel electrophoresis and
resolved by electrophoresis distance of up to 10 centimeters
from the loading wells. All markers were chosen from the
Mouse Genome Informatics (MGI) database links (http://
www.informatics.jax.org/searches/probe report.cgi? Refs
key=22816 and ftp://ftp.informatics.jax.org/pub/data-sets/
index.html (numbers 7 and 12 in the list)).
2.2. Mice Strains. The mice were purchased from Charles
River Laboratories or The Jackson Laboratory. The strains,
the rationale for including these strains in the panel, and the
vendors are listed in Table 1.
2.3. DNA Extraction, PCR Amplification, and Agarose Gel
Electrophoresis. The DNA samples were extracted from the
tail pieces of about 3–5mm length using Gentra Puregene
Tissue Kit (Cat. # 158622). Twenty ul PCR reactions were set
up using 1X reaction buffer containing 20mM Tris pH 8.4,
50mMKCl, 3mMMgCl
2
, and 1 unit of TaqDNA polymerase
(New England Biolabs, Cat. # M0273) under the following
conditions: one cycle of 95∘C –2min followed by 35 cycles of
95∘C –30 sec, 55∘C – 30 sec, and 72∘C–60 sec and one cycle of
72∘C – 5 minutes, followed by a holding temperature at 4∘C
until the samples were removed from the machine. Fifteen ul
of PCR products was resolved using 4% agarose gels for 120
to 150 minutes at 200-constant-volt electric current. The
agarose was purchased from Phenix Research Products (Item
Number RBA-500: Molecular Biology Grade) and the gels
were prepared on 0.5XTAE buffer diluted from a stock of 50X
(Fisher Scientific, Cat. # BP1332-20). The gels contained
ethidium bromide dye (0.5 𝜇g/mL) to aid the visualization of
PCR bands. Each panel of gel included one or more lanes of
100-base-pair molecular weight marker (New England Bio-
labs, Cat. # N3231) to assess the PCR product sizes. The bro-
mophenol blue dye-front was allowed to run for up to 10
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centimeters from the wells and the gels were imaged using
BioRad Gel Doc XR system. Wherever necessary, the gels
were run longer to resolve the bands.
2.4. Analysis and Interpretation of Polymorphic PCR Bands.
The cropped images were imported into an Excel file for anal-
ysis and interpretation. Band sizes were assigned numbers 1,
2, 3, or 4 to indicate their sizes compared to the rest of the
bands in that set. Number 1 was assigned to the smallest sized
polymorphic band, 2 to the next biggest in the group, and so
on.TheExcel file alongwith the gel imageswas converted into
a .pdf file for generating Figure 1.
3. Results and Discussion
Mutant mice created using transgenic and knockout tech-
niques are available under certain specific backgrounds. In
order to best use suchmutants for a specific research purpose,
they routinely need to be bred into other strain backgrounds
through successive breeding of about 10 generations. A
quicker way to attain highest recipient genome can be
achieved by a process called speed congenic breeding in
which the polymorphic markers between the recipient and
donor strains are screened among offspring in each gen-
eration and the offspring with highest recipient genome is
chosen as a breeder for the subsequent generation [19–21].
Although there are a few reports describing the marker sets
suitable for certain pairs of strains, there are no well-
established marker sets available across the most commonly
used strains in transgenic and knockout mouse techniques.
Our primary objective of this work was to test the suitability
of several markers in an agarose gel electrophoresis method,
a technique that uses least expensive equipment and reagents
and is readily available in most molecular biology labora-
tories. We sought to test a large number of microsatellite
markers (Tables 2 and 3 and S1 in Supplementary Mate-
rial available online at http://dx.doi.org/10.1155/2015/735845)
among 10 most commonly used mouse strains particularly
those used in transgenic and knockout mice techniques.
We used Mouse Genome Informatics (MGI) database
and short-listed the primers based on the criteria described
in Section 2. MGI database lists several of the microsatellite
markers identified in various inbred strains. Although the
database is extensive, it is difficult to choose marker sets for
speed congenic screening because it lacks the critical infor-
mation such as the sizes of PCR products of various markers
in different inbred strains and if the differences among
strains can be identified using conventional agarose gel
electrophoresis.
As per the information available on MGI database,
predicted PCR band size differences among strains for some
markers ranged from as few as a few base pairs to over 100
base pairs. Selection criteria for markers and the mice strain
are described in Section 2. Taking C57BL6J and 129X1 strains
as a comparison pair, for example, we chose markers with
differences of 30 bp and above (as per MGI database), a
range that can be easily resolved using about 2% agarose
gels. We aimed to choose markers in this range for all
the chromosomal locations with an interval of 5 to 15 cM.
However, we were unable to find suitable markers in some
regions with this criterion. In such locations, we tested
markers with as less as 8 to 12 bp size difference. Such small
differences can be best resolved using polyacrylamide gel
electrophoresis (PAGE). However, in a typical speed congenic
screening that involves analysis of about 100markers for each
sample, applying PAGE method for screening becomes quite
laborious. We used 4% agarose gels to resolve makers even
with very small size differences; this seemed to be sufficient to
resolve the bands when they were run about 8 to 10 cen-
timeters from the loading well. In order to keep the assay
conditions uniformweused 4%agarose gel for all themarkers
tested.
Table 2 shows the list of the markers tested and found
polymorphic in at least one of the 10 strains analyzed. We
tested a total of 423 markers of which we present useful data
for 195 markers. The gel images and interpretation of poly-
morphisms are tabulated in Figure 1. The gel images indicate
that there were readily appreciable size differences for most
markers whereas some markers showed very narrow size dif-
ference between some strains. In general, sizes of themajority
of the markers matched the information on MGI database
but there were some discrepancies noticed. The agarose
gel electrophoresis using 4% gels could be useful in detecting
differences among the markers in different strains.
The data presented in Figure 1 indicate that somemarkers
could readily distinguish several strains from each other. We
initially aimed to identify good panel of markers for every
10 cM. Although we found adjacent markers as close as 10 cM
in most locations, we failed to achieve this in some regions.
We screened several available markers in such regions and
were unable to findmarkers thatmatched the criteria set forth
in our assay. It should be noted that there were markers that
differed very minutely among some strains. If such markers
are chosen in an actual speed congenic screening, we rec-
ommend including samples from both donor and recipient
strains and an equimolar mixture of the two in the panel in
order to ensure the proper banding pattern of offspring. The
gel images and the interpretation of polymorphism provided
in Figure 1 will serve as a comprehensive tool for a researcher
who wishes to undertake congenic breeding in a pair of
strains from the list.
The data from the markers that did not meet our criteria
fell into one of the following categories: it (1) yielded the same
size bands in all the strains, (2) failed to amplify a product
in some strains, (3) amplified multiple PCR products, or (4)
did not yield a reliable PCR product in most/all of the strains.
Category 1 means that the bands were not resolvable by 4%
agarose gels.We presume that suchmarkers would be<6 base
pairs different from one another [31] or they do not differ in
size at all. Category 2 would probably mean that the primers
did not have perfect binding sites in those strains where there
was no PCR product. Category 3 makers may need further
optimization of PCR conditions. However, one of our aims
was to keep the conditions uniform to all themarkers in order
to keep the assay simple: it makes the assay cumbersome if
PCR conditions have to be varied among different marker
sets. It should be noted that the category 4 markers (that did
4 International Journal of Genomics
Marker (cM) Gel image
F
V
B
/
N
J
C
5
7
B
L
6
/
J
1
2
9
X
1
/
S
v
J
1
2
9
S
2
D
B
A
2
/
J
C
B
A
/
J
S
J
L
/
J
B
a
l
b
/
c
C
3
H
/
H
e
N
O
D
D1Mit231 6.5 1 2 2 2 1 1 1 1 1 2
D1Mit211 10.59 2 1 2 2 2 2 1 3 2 2
D1Mit213 22.88 1 2 1 1 1 1 1 2 1 1
D1Mit303 31.79 1 2 1 1 1 1 1 2 1 1
D1Mit46 39.16 3 1 2 2 2 2 2 1 3 3
D1Mit440 44.98 2 1 2 2 1 1 1 1 1 2
D1Mit218 55.76 2 1 2 3 2 1 1 2 2 1
D1Mit200 63.84 3 1 1 1 2 3 3 1 3 1
D1Mit369 63.51 2 1 1 1 1 1 3 2 2 3
D1Mit507 72.38 1 3 3 3 2 3 4 3 3 4
D1Mit150 81.08 2 3 1 1 1 1 2 1 1 1
D1Mit407 89.89 2 1 2 2 2 2 2 2 2 2
D1Mit155 98.2 1 2 1 2 1 1 1 1 1 1
D2Mit1 2.23 3 1 1 1 1 1 2 1 1 1
D2Mit149 10.04 3 3 1 2 3 2 3 2 2 2
D2Mit152 21.81 2 1 2 2 1 1 1 1 1 1
D2Mit367 22.5 2 1 1 1 2 1 1 1 1 2
D2Mit323 31.42 3 3 1 2 3 2 3 2 2 2
D2Mit328 42.89 3 2 1 1 2 2 2 3 2 3
D2Mit42 54.85 1 3 1 1 4 2 1 4 3 1
D2Mit395 59.97 3 1 3 3 2 1 3 2 1 1
D2Mit106 64.78 1 1 2 2 1 2 2 2 2 2
D2Mit107 65.13 1 1 1 1 1 2 1 1 2 1
D2Mit309 75.03 1 1 3 3 1 1 1 1 1 2
D2Mit285 75.41 3 1 3 3 2 2 2 2 2 1
D2Mit48 77.36 1 2 1 1 2 1 1 1 1 1
D2Mit311 86.02 1 4 3 3 1 2 1 2 1 2
D2Mit265 97.97 3 1 2 2 2 3 3 3 2 1
D2Mit148 100.49 1 2 3 3 2 3 4 3 2 2
D2Mit266 103.83 1 2 1 1 1 1 1 1 1 1
Band size interpretation
Figure 1: Continued.
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D3Mit60 1.96 1 2 1 1 1 1 1 2 2 1
D3Mit164 2.1 1 2 2 2 1 1 1 1 1 1
D3Mit203 10.82 1 2 1 1 2 1 2 3 1 2
D3Mit 49 21.6 1 2 2 2 3 1 1 3 1 3
D3Mit51 35.2 3 2 2 2 3 1 2 2 1 2
D3Mit10 43.03 3 3 2 2 3 2 3 2 2 1
D3Mit189 43.89 1 1 1 1 2 2 1 2 2 2
D3Mit318 54.58 1 1 2 2 1 3 1 3 3 1
D3Mit256 63.04 1 2 3 3 1 1 1 1 1 2
D3Mit19 87.6 2 1 1 1 3 3 2 3 3 3
D3Mit116 79.23 2 1 1 1 2 1 2 2 2 2
D4Mit227 4.43 1 2 1 1 2 2 3 2 3 3
D4Mit193 13.99 1 2 1 1 1 1 1 1 1 1
D4Mit17 33.96 1 2 1 1 1 1 1 2 2 1
D4Mit27 42.13 3 3 2 2 3 1 1 1 1 2
D4Mit31 50.04 3 2 3 3 2 1 1 1 1 1
D4Mit308 57.66 4 1 2 2 3 3 3 3 3 4
D4Mit203 63.26 3 1 1 1 2 2 3 2 3 2
D4Mit251 69.05 2 1 1 1 2 2 2 2 2 2
D4Mit354 76.12 3 2 2 2 3 1 3 2 1 2
D4Mit42 82.64 1 3 2 2 1 1 1 3 2 3
D5Mit145 3.37 2 4 3 3 4 4 2 2 4 1
 D5Mit73 12.88 2 2 1 1 2 2 2 2 2 2
D5Mit352 18.4 3 1 1 1 3 2 2 2 2 3
D5Mit233 28.55 3 1 1 1 2 3 2 3 3 3
D5Mit307 40.31 1 1 1 1 3 2 3 2 2 2
D5Mit277 51.70 2 1 1 1 1 2 2 1 2 1
D5Mit158 55.99 2 1 1 1 1 2 2 1 2 2
D5Mit161 65.34 2 1 3 3 3 2 2 2 2 4
D5Mit99 79.51 2 1 2 2 2 1 3 3 3 3
D5Mit43 84.68 2 1 2 2 1 1 3 1 1 2
Band size interpretation
Figure 1: Continued.
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D6Mit296 2.25
D6Mit116 11.5
D6Mit274 23.70
D6Mit8 35.94
D6Mit100 41.03
D6Mit36 48.93
D6Mit10 52.75
D6Mit333 60.55
D6Mit302 67.66
D6Mit14 77.64
D7Mit21 1.91
D7Mit152 2.71
D7Mit57 9.94
D7Mit267 17.09
D7Mit158 29.82
D7Mit317 41.50
D7Mit194 44.83
D7Mit220 55.69
D7Mit101 69.01
D7Mit223 88.85
D8Mit143 11.59
D8Mit63 19.02
D8Mit178 34.43
D8Mit45 42.16
D8Mit80 43.06
D8Mit211 52.0
D8Mit215 62.63
D8Mit56 76.14
D9Mit249 2.46
D9Mit250 2.46
D9Mit89 14.79
D9Mit285 21.42
D9Mit336 35.39
D9Mit8 42.65
D9Mit347 55.11
D9Mit18 71.49
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Figure 1: Continued.
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D10Mit28 3.04 2 1 1 2 2 1 1 1 1 2
D10Mit213 9.75 1 2 1 1 1 2 1 1 1 3
D10Mit108 22.89 2 2 1 1 2 2 2 2 2 2
D10Mit20 34.83 2 1 2 1 2 1 1 2 1 2
D10Mit230 45.28 2 1 2 1 2 1 1 2 1 2
D10Mit96 51.19 1 2 2 2 2 1 2 2 1 1
D10Mit178 51.42 1 2 2 2 2 1 2 2 1 2
D10Mit233 61.58 2 1 2 1 2 1 2 1 2 1
D10Mit271 72.31 1 2 2 2 2 1 1 2 1 3
D11Mit1 2.51 1 1 2 1 1 1 1 2 1 1
D11Mit226 5.64 1 2 1 1 1 1 1 1 1 1
D11Mit151 15.29 3 2 3 3 2 1 3 3 2 3
D11Mit217 23.1 1 3 3 3 1 3 3 3 3 2
D11Mit349 33.29 1 2 1 1 1 1 1 2 1 1
D11Mit298 42.76 4 2 3 3 1 2 2 2 2 4
D11Mit39 52.22 1 2 1 1 1 1 1 1 1 1
D11Mit70 58.9 2 3 3 3 3 1 3 3 1 3
D11Mit54 59.82 1 2 1 1 1 1 1 1 1 1
D11Mit132 62.92 2 1 2 2 2 1 1 1 2 2
D11Mit333 71.83 2 3 2 2 2 1 3 2 2 2
D11Mit303 82.9 2 1 3 3 2 3 4 3 3 2
D12Mit12 8.49 2 1 2 2 2 3 2 4 3 4
D12Mit2 18.94 2 1 1 1 2 1 2 1 1 2
D12Mit114 28.94 3 1 2 2 3 3 1 2 3 1
D12Mit149 36.85 1 2 3 4 3 3 3 3 3 1
D12Mit117 43.32 1 2 2 2 2 2 2 2 2 1
D12Mit30 50.43 1 1 2 2 1 1 1 1 2 1
D12Mit99 52.9 1 1 2 2 2 2 1 2 1 1
D12nDs2 62.22 3 4 3 3 2 1 4 3 2 4
D12Mit263 62.11 3 1 2 2 3 3 1 2 3 1
D13Mit16 7.26 1 3 1 1 3 3 1 1 3 2
D13Mit137 18.87 1 1 2 2 1 1 1 1 1 1
D13Mit63 21 2 1 2 2 2 2 2 2 2 2
D13Mit186 31.87 3 1 1 1 1 1 1 2 1 1
D13Mit282 32.59 1 3 3 3 3 3 3 3 3 2
D13Mit191 45.05 2 1 3 3 2 2 2 2 2 2
D13Mit51 56.45 1 2 1 1 2 1 1 1 1 2
D13Mit213 59.69 2 1 2 2 2 2 2 2 2 1
D13Mit78 67.21 1 2 2 2 2 2 1 1 2 1
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D14Mit179 4.92 1 1 1 2 1 1 1 1 1 1
D14Mit126 11.94 1 2 3 2 2 2 2 3 3 2
D14Mit60 24.6 1 3 2 2 1 2 1 2 2 1
D14Mit259 27.65 3 1 2 2 2 2 3 2 3 2
D14Mit39 35.69 2 2 1 1 1 2 2 2 1 2
D14Mit68 37.61 2 1 1 1 1 1 2 1 1 1
D14Mit194 45.96 1 2 2 2 1 1 2 1 1 1
D14Mit95 57.2 1 1 2 2 2 1 1 1 1 2
D14Mit97 62.20 1 3 2 2 3 3 1 3 3 2
D15Mit13 1.84 3 2 1 1 1 3 3 3 3 4
D15Mit265 6.08 3 3 3 3 1 1 2 1 1 2
D15Mit138 15.68 2 2 4 4 3 3 3 3 1 3
D15Mit154 16.82 1 2 1 1 2 2 3 3 1 2
D15Mit128 25.58 2 1 1 1 1 2 1 1 2 1
D15Mit92 32.19 2 3 2 2 1 2 2 2 2 3
D15Mit80 38.02 1 2 2 2 2 1 3 1 1 1
D15Mit34 45.31 1 1 1 1 2 1 3 3 1 1
D15Mit244 48.65 2 1 1 2 2 2 2 1 2 2
D15Mit16 58.05 2 1 1 1 3 1 3 2 2 3
D16Mit131 3.41 2 1 3 3 3 3 3 3 3 3
D16Mit136 27.82 1 2 3 3 2 3 2 3 4 3
D16Mit30 33.01 1 2 2 2 2 3 2 2 1 2
D16Mit64 34.22 1 2 2 2 2 3 2 2 2 2
D16Mit140 40.30 2 1 2 2 2 2 2 2 2 2
D16Mit19 45.36 2 1 2 2 2 2 2 1 1 2
D16Mit70 48.81 1 2 1 1 1 1 1 1 1 1
 D16Mit71 57.06 2 1 2 1 1 1 1 1 1 1
D17Mit164 2.11 2 3 2 2 3 3 3 3 3 1
D17Mit133 12.53 1 3 1 1 2 1 1 1 1 2
D17Mit51 19.74 1 2 2 2 2 1 2 2 1 2
D17Mit68 23.55 2 1 2 2 2 2 4 3 2 4
D17Mit20 29.73 1 2 2 2 1 1 2 1 1 1
D17Mit205 39.3 2 3 2 1 2 2 2 3 2 3
D17Mit1002 50.97 1 1 1 2 1 1 1 1 1 1
D17Mit123 60.67 3 1 2 4 4 3 4 3 4 2
Band size interpretation
Figure 1: Continued.
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D18Mit222 8.08 2 2 2 2 2 1 2 1 1 1
D18Mit226 18.18 2 1 2 1 1 1 2 2 2 2
D18Mit177 21.39 1 2 3 3 3 3 1 3 2 3
D18Mit91 29.67 3 2 3 3 1 1 4 3 2 2
D18Mit124 32.15 1 3 2 2 2 3 2 3 2 2
D18Mit184 39.70 3 4 1 1 1 1 3 2 1 3
D18Mit186 45.63 1 2 1 3 3 3 3 2 3 2
D18Mit7 51.92 2 1 4 4 3 3 1 1 3 1
D18Mit129 53.28 2 1 2 2 1 1 1 1 1 1
D19Mit68 3.38 1 2 2 2 2 2 1 1 1 1
D19Mit60 13.9 1 2 2 2 2 2 1 2 2 1
D19Mit45 16.14 3 2 2 2 1 1 3 2 1 1
D19Mit30 21.34 1 3 1 3 3 3 3 2 3 2
D19Mit88 32.23 1 2 2 2 2 2 2 2 2 2
D19Mit19 34.08 1 2 2 1 1 1 1 1 1 1
D19Mit11 36.26 3 1 1 4 2 4 4 3 4 3
D19Mit91 40.53 3 2 2 3 3 1 3 3 1 1
D19Mit1 50.32 2 1 1 2 2 2 2 2 2 2
D19Mit71 56.28 2 1 1 2 1 1 2 2 1 2
DXMit136 4.23 1 1 2 2 1 1 1 1 1 1
DXMit48 25.51 1 2 1 1 2 2 1 1 2 1
DXMit62 34.6 2 2 1 1 1 2 1 2 2 1
DXMit110 35.53 2 1 2 2 2 2 1 1 1 1
DXMit170 45.87 2 1 2 3 1 3 1 3 2 1
DXMit179 53.17 1 1 1 1 1 1 1 1 1 2
DXMit79 68.46 1 1 2 1 1 2 1 2 2 1
DXMit153 73.26 1 1 2 1 1 1 1 2 1 2
Band size interpretation
Figure 1: Agarose gel images of PCR bands and their interpretation. Bands were assigned numbers 1, 2, 3, or 4 to indicate their sizes compared
to the rest of the bands in that set. Number 1 was assigned to the smallest sized polymorphic band. 2, 3, and 4 represent the successive bigger
sized bands.
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Table 2: Primer sequences used for PCR amplification of SSLP markers.
Marker cM Primer F Primer R Product size Lab code
D1Mit231 6.5 ACCCACAATTGCCTGTGG GTCTTTGCAAGCCACCAAAT 267 1-1
D1Mit211 10.59 GTTATTCATCAAAATACAGATGGCC TCTGCTGCTAAGTAGAATGAATGC 135 1-2B
D1Mit213 22.88 TTCTTAGAAGTGATAAAAGTTTCAGCA AAAATTCCAGAATTCTCACTACGG 108 1-2
D1Mit303 31.79 GGTTTCTATTTCGGTTCTCGG TCTGTGCTGCAAAACAGAGG 128 1-3
D1Mit46 39.16 AGTCAGTCAGGGCTACATGATG CACGGGTGCTCTATTTGGAA 253 1-4
D1Mit440 44.98 TCCACACAAGGTGTCCTCTG GCTCAGGTGACCTCCAAAAC 114 1-5B
D1Mit218 55.76 TGCAAATGTTACTTTAGTCTCTAGTGG AGTTTTGGTGAGTGATCTTATCCC 145 1-218
D1Mit369 63.51 ACTTGTTTGTTGCTGAGGTTCA GCTTATGAACCCACCCTCAA 141 1-5Q
D1Mit200 63.84 GCCATGTTCATGTACATAGGTAGG ATGGATGGATGGTTTTCCTG 199 1-200
D1Mit507 72.38 GTTGGAAAGACTGTTTACAATTCG GTTCCAGCCTTTGCCCTTAC 115 1-6
D1Mit150 81.08 CTGGTGTCCACACACAGGTC TGATTGCAATATACCAGGTTTCC 138 1-150
D1Mit407 89.89 GAGAACAACCAGCCACCAAT ATATTTGCTTTGAAGTTACTTTGTGTG 119 1-407
D1Mit155 98.2 ATGCATGCATGCACACGT ACCGTGAAATGTTCACCCAT 252 1-7
D2Mit1 2.23 CTTTTTCGTATGTGGTGGGG AACATTGGGCCTCTATGCAC 123 2-1
D2Mit149 10.04 ATATCATATAGTAGAGAAAGCGTGCTG TCATTAGACTTGGAAAAAAGTTTGC 199 2-1P
D2Mit152 21.81 CACAGATCTTGTAAGACCACGTG TGCCATGAGTGTGGGACTAA 109 2-2
D2Mit367 22.5 GCCTGTGCTAAAAAAGAGGTG GCCCTGAGAACTACCCTCCT 149 2-367
D2Mit323 31.42 AGAATCCTAAGTGGTGGTTAGAGG ACCCAAAGTTGTCTTTAAGTACACA 125 2-2P
D2Mit328 42.89 CTTTCAATGTTCCGGCATG AAGACTTGCTTTCATTAGACCACA 235 2-3
D2Mit42 54.85 ATTACTGGGCAGGAACATTTG GCCAAACTTCCAGACTCCTC 132 2-3B
D2Mit395 59.97 AGGTCAGCCTGGACTATATGG AGCATCCATGGGATAATGGT 125 2-4
D2Mit106 64.78 GAGGGTTGCCAAAGAGACTG CACCTCAGGGGAACATTGTG 150 2-4P
D2Mit107 65.13 GGGAGTGAAGCCAGCATAAG AACTGACTGAGTTTCAAAGTGCC 119 2-107
D2Mit309 75.03 ACAAATGCCACTCTCACATCC TATTTCTCAGAGTCACTAGGAGTGATG 119 2-309
D2Mit285 75.41 TCAATCCCTGTCTGTGGTAGG TATGACACTTACAAGGTTTTTGGTG 141 2-5
D2Mit48 77.36 GCTCTGCAGAAGATGCTGC GCTGAGACGCAGAGTCGC 130 2-5B
D2Mit311 86.02 ACAGGCAGCCTTCCCTTC TCTGTCCCGCTTCTGTTTCT 126 2-5D
D2Mit265 97.97 AATAATAATCAAGGTTGTCATTGAACC TAGTCAAAATTCTTTTGTGTGTTGC 105 2-6P
D2Mit266 103.83 GGATCTATGCTCCATTTTAATTGC TCATCTTCTGGTTTCAACATGG 127 2-6
D2Mit148 100.49 GTTCTCTGATCTACGGGCATG TTCACTTCTACAAGTTCTACAAGTTCC 115 2-148
D3Mit60 1.96 GACATCCTGGGCAACATTG GGTGTTGTTTGCTGTTGCTG 170 3-1
D3Mit164 2.01 GCTCCTGGGAAAGGAAGAAT GATACTTGGGGTTGTGCATACA 135 3-164
D3Mit203 10.82 CTGAATCCTTATGTCCACTGAGG GGGCACCTGCATTCATGT 150 3-2
D3Mit51 35.2 GGCACTGATAGCAGGCCTAG TCTCTTCTGGTATTTCCTTCCG 248 3-3
D3Mit 49 39.02 CTTTTCTCGCCCCACTTTC TCCTTTTAGTTTTTGATCCTCTGG 132 3-49
D3Mit10 F 43.03 CTGGCTTGGTGGAAGTCCT CCTAAGCCAGCTACCACCAC 142 3 10
D3Mit189 43.89 GTTACCACCCAGAGAAAAGGC TACTCCTCGCTGCTTCCCTA 133 3-189
D3Mit318 54.58 CTCATTCCTTCTGAGCAATGG TATGGGATATGCTTTTCATAAAAGG 148 3-318
D3Mit256 63.04 TACATTGCTTTTTGCTTTGAGTG GTCGAATGTTATCAGAATTTGCA 125 3-4
D3Mit116 79.23 TCACTGCCCATCTTTGTAACC CCCAGAGACCCGGAATAGAA 259 3-116
D3Mit19 87.6 CAGCCAGAGAGGAGCTGTCT GAACATTGGGGTGTTTGCTT 159 3-5
D4Mit227 4.43 CTCAGACATGATTTTTTCCAAGG GCAGTTAAACTGTACTTTCTGTAAACA 181 4-1
D4Mit193 13.99 TATTTTAATTTTAGCCCATCAGGG AAAGACATACAATTGATCCACAGG 136 4-1B
D4Mit17 33.96 TGGCCAACCTCTGTGCTTCC ACAGTTGTCCTCTGACATCC 147 4-2
D4Mit27 42.13 GCACGGTAGTTTTTCCAGGA TGGTGGGCAGGCAATAGT 150 4-2B
D4Mit31 50.04 ACGAGTTGTCCTCTGATCAACA AGCCAGAGCAAACACCAACT 121 4-2C
D4Mit308 57.66 TATGGATCCACTCTCCAGAAA CAAAGTCTCCTCCAAGGCTG 88 4-3
D4Mit203 63.26 GAATTCTTCCTGGGCCTTTC CAAGAGCCCAGGTGTGGTAT 105 4-3B
D4Mit251 69.05 AAAAATCGTTCTTTGACTTCTACATG TTTAAAAGGGTTTCTTTATCCTGTG 114 4-4
D4Mit354 76.12 TTGATCTGTCGTGGATTCCA AGACAGACACATAGACACAGACATAGG 111 4-4B
D4Mit42 82.64 CATGTTTGCCACCCTGAAAC CCTCACTTAGGCAGGTGACTC 100 4-5
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Table 2: Continued.
Marker cM Primer F Primer R Product size Lab code
D5Mit145 3.37 TATCAGCAATACAGACTCAGTAGGC TGCCCCTTAAATTCATGGTC 150 5-1
D5Mit73 12.88 GTTTGAGAGGTCCTGAAAGCA TTTCCATTTACATACATTTGTGCA 113 5-1B
D5Mit352 18.4 CCCAGAGCCCACATCAAG TAGGTGGGTGTGTCTCTCCC 110 5-2
D5Mit233 28.55 TCCCCTCTGATCTCCTCAGA CCTCCTAGAATACAATTCAATGTGG 147 5-3
D5Mit307 40.31 AGTGGCATAACTTCATTCAATAATG GGAATCAAGTTGTTTTTTAAATTTACC 120 5-3P
D5Mit277 51.7 GTGTGTTTGTGCATGGGTATG ACCATCGGGAAAAAATGTAGC 123 5-4B
D5Mit161 65.34 CACACGCATAGTCTTGTGGG GCATGTTCAACTGTGCTTTCA 119 5-5B
D5Mit99 79.51 CAGAAAAGAGAAAACGGAGGG TTCCTGCTGCCTGAAGTTTT 200 5-5C
D6Mit138 1.81 GCTCTTATTAATGAAGAAGAAGGAGG CAAAGAAAGCATTTCAAGACTGC 135 6-1
D6Mit296 2.25 TCGGGCATCTTTATTTTTGC TAGTGCAGCACACCCCCT 100 6-296
D6Mit116 11.5 ACATTTCTTTGTGAGGTTCCTTG CAGGTTTTTTGAAAGACACTCTTG 122 6-1B
D6Mit274 23.7 GCAATGCCAAAATGTTCAAA TCCTTCTCCATTTACACTTACAACA 113 6-1D
D6Mit8 35.94 TGCACAGCAGCTCATTCTCT GGAAGGAAGGAGTGGGGTAG 163 6-2B
D6Mit100 41.03 CTTGAGTAGGTCTCAGTGCGG CACATGCACACACAGAAGCA 84 6-3
D6Mit36 48.93 ACCATCTGCATGGACTCACA GTTGAAGAGGACGACCAAGTG 196 6-4
D6Mit10 52.75 TCAGAGGAACAAAGCAGCAT CCTGTGGCTAACAGGTAAAA 200 6 10
D6Mit333 60.55 TCCTCACTACAATTCATCTATTACTGC TGCTTCTGGTATAGGCAGTTAGG 122 6-333
D6Mit302 67.66 AATGACCCTGGTTAGTGTCAGG GAATTCCATTCGAGGGGC 113 6-4C
D6Mit14 77.64 ATGCAGAAACATGAGTGGGG CACAAGGCCTGATGACCTCT 157 6-5
D7Mit21 1.91 GGGTTGAACCTTACAGGGGT ATCAAACCAGCCCAAGTGAC 192 7-0A
D7Mit152 2.71 GCCTAGCACACGCCAAAG CCTTGTGCATGGTTGCTATG 129 7-152
D7Mit57 9.94 TTCCCTCTAGAACTCTGACCTCC AGTTCAGAGCCGAGACTAGGC 148 7.-1
D7Mit267 17.09 CTCTTTCTGTTACATGGTTAGATTTCC AAAGACAGTTGAAGTTGACTTCTGG 192 7-2
D7Mit158 29.82 CTTCATCTGAGCCTGGGAAG ACTGTAGACCCATGTTCTGATTAGG 149 7-158
D7Mit317 41.5 ATGTCTCCTTGACATTGGGC TCTTGTAATCTCACATCTAAGTGTGTG 102 7-2D
D7Mit194 44.83 GTGCAACACACAGAAAAGTTCC AAAGGCTCACAACGGACTGT 146 7-194
D7Mit220 55.69 AAGCATGCAAGCACACTCAC ATGCACACAGGCAGTCACTC 135 7-3A
D7Mit101 69.01 TACAGTGTGAACATGTAGGGGTG TCCCAACATGGATGTGCTAA 111 7-4
D7Mit223 88.85 ATGCACATGAGTGTGTGTATGC TCCTGTGTCTGACGCTCATC 106 7-5
D8Mit143 11.59 AGCCTGAGGTTATGTTTTTTGC GGCCCTCAGGTTTTCTCTCT 279 8-143
D8Mit178 34.43 AAAATCAACTGTTTACATTTGAGCC AGAGCACGCAGTGTGTATGC 148 8-2
D8Mit45 42.16 GAACAGGACCAATAAAATGAAAGC CTACCTTACCAAACTTCCCGG 121 8-45
D8Mit80 43.06 TGCATTTGTCAGGGCTCTC ATGACACATGAGCCTCCACA 107 8-080
D8Mit211 52 CAGAACACTGTCCTGAAAAGTCC TACCCACAAACCTGTATTTAAATTAA 149 8-4
D8Mit215 62.63 AATACACAAGGTTGGCCTCA ATGTGTGGATATTCATGTGCTC 178 8-5
D8Mit56 76.14 ACACTCAGAGACCATGAGTACACC GAGTTCACTACCCACAAGTCTCC 162 8-56
D9Mit250 2.46 CCCAAAAACCTATTTGCAGTG GTGACATGATTCCTTCAGTCTTACC 123 9-1
D9Mit249 2.46 AAGCCCTCTTAGAAGTAGTGTGTATG AGCCATGAACTAACTTACATGTATCA 125 9-249
D9Mit89 14.79 CACATACAAGGATATACATACACAGGC TCACAGGAGGTGGCAGAAAT 145 9-89
D9Mit285 21.42 CAAATACATTGCTGATTATATCAGAGA GGACTCTAGATCTCATCAGGGA 125 9-2
D9Mit336 35.39 AAGTGGTTCACAGAAATGTATACAGG TTTTCTTTCTGTGGTAAAGGGG 122 9-3
D9Mit8 42.65 GATGAAGACAATAAAGAACCTTAAA AAGAGCTAACCCATTGCTGC 183 9-3B
D9Mit347 55.11 CCTCCACATGTGCACTGCT CTGTCCATCTATCATCTATCTGTCTG 122 9-4
D9Mit18 71.49 TCACTGTAGCCCAGAGCAGT CCTGTTGTCAACACCTGATG 180 9-5
D10Mit28 3.04 CCTCCTGTATGTGTATTTAAAGCA CTGCCCATCTGACCCTGATA 147 10-1A
D10Mit213 9.75 CTCCTCCTACTGATTGTCCCC GGGACAAACTTTTAAAAATTGCA 150 10-2
D10Mit108 22.89 TGCCTGTAACCTGCATACCC GTTTAACACCCAGGACTATACATGG 142 10-108
D10Mit20 34.83 CACCCTCACACAGATATGCG GCATTGGGAAGTCCATGAGT 234 10-3
D10Mit230 45.28 AGATAGCCTAGGGGGTGCAT ATCAGTTTCCAATCGCTGCT 115 10-4
D10Mit96 51.19 CTTCTTTGAAGTTAGATGCAGCC TACGGAGAAGGGAACACCTG 150 10-096
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Table 2: Continued.
Marker cM Primer F Primer R Product size Lab code
D10Mit178 51.42 ATTGTCAAATATCTTCCTCAGTTGC TTATTCCTAGGCAGTCTGTCTGG 133 10-4B
D10Mit233 61.58 GTGCTTTATATTGGAGATCATCACA GTCCCGAATTTCACATACATAGC 130 10-5
D10Mit271 72.31 ACAACCAAAGGTCTTTGTAGAAGA AATATATAGGCACACCTTAATAGCCA 117 10-6
D11Mit1 2.51 GGGTCTCTGAAGGCTTTGTG TGAATACAGAAGCCACGGTG 153 11-1P
D11Mit226 5.64 AGGTGAACTCTTTTGAAGTTTGTG AAAGGAGTGACTGAGAAAGACACC 139 11-226
D11Mit151 15.29 TGGGAATTCTGGGAGTTCTG GTTGGTCTGTTATGAAGACCAGG 140 11-1Q
D11Mit217 23.1 ACTGGAAAATATGTTTTAAACCTCTG AAATGGGATTCTGCAAAAACC 135 11-217
D11Mit349 33.29 AGTATCAGAAGATCCAGTTGGAGG GTAGAAAAAGATACCCAGTGTCAGC 118 11-349
D11Mit298 42.76 AAACAAACAAAAATGCACCTCA GTACCACCATGCCTAGCCTC 199 11-298
D11Mit39 52.22 TTTCATGACCCCTAATTTCCC GTGGGTGTGCCTGTCAATC 155 11-39
D11Mit70 58.9 GGAAGTAGCTATGGAGGTGGC TCTGACCCAGAGCTCAAATACA 140 11-70
D11Mit54 59.82 AGGCTGGTGGCTAGTGTCC AAGTCTTGCGCTGCATCTTT 144 11-4A
D11Mit132 62.92 GGTCAGAGGACAATCTTACATGC GTTCCAAGACAATGAGAGACCC 117 11-4B
D11Mit333 71.83 CATGTGGTTATTTTCTAGCCCC AGGCATCAATAACTATTTTTCAGTG 125 11-5
D11Mit303 82.9 TCAATCTCTCAAGTTTTTCCAGC GACAACGTTGACCTCCACG 106 11-6
D12Mit12 8.49 TTCAATGCCTTCTGGCTTCT GATTACCGGGTGTGTGACCT 145 12-1
D12Mit2 18.94 ACACAGGCTAAAACATGGGC GCATCTGTATTCCACAGGCA 134 12-2
D12Mit114 28.94 TTGACCTTGAACTTGTGACCC GTTTTCTCCAAATCACTGTCACC 144 12-3
D12Mit149 36.85 CATGGCACACATACATACATGTG AACATAGCAATGGTATATAGGTATGGG 132 12-3B
D12Mit117 43.32 AATTGAGGAACTTAGAAGAAAAGCC CCTCTGGCCACCATACATG 127 12-117
D12Mit30 50.43 TATGTGACTGCAATCCCAGC ATGAACACATCATGCCCAGA 107 12-30
D12Mit99 52.9 CTTACAGAAAATGAAAACCAAAACA CCTCTGCTTTAGAGGCAAACG 151 12-099
D12Mit263 62.11 TCAGATCTCAGCAGATAAATACTTGG TCCCCTGGAGCATATTTGAC 113 12-6
D12nDs2 62.22 ACATGGTAATTTATGGGCAA CTGGATACCTGCAATAGTAGA 195 12-5
D13Mit16 7.26 CCAGCTGAAGGCTTACTCGT AAAGTTAGAATCAGCCATTCAAGG 207 13-1
D13Mit137 18.87 GAATCAGAGAACCTGGCTGTG TCTAAAAGAGAGAAAATTGGGGC 131 13-137
D13Mit63 21 GAGATGGAAGGAAGAGATGGC CAAATGCATGTATCCGTATGTG 139 13-63
D13Mit186 31.87 GAAAGCCCTAGGGGAAGATG TGCAGTTTCTAAGGTTAAAACTAAAGC 149 13-3
D13Mit282 32.59 TCGCACTTCCTATACAGTTATAAGAG GGACAGAAAGCATGCAGAGG 125 13-282
D13Mit191 45.05 GCAAATTAGAGAATCATGCATCC TGGAGAATGCTAAAAGCATGG 119 13-3B
D13Mit51 56.45 TCCTGCAAAAGTGGAGCC TGGAAACAAGCTCTTGGAGG 146 13-3P
D13Mit213 59.69 GCCTGAAACTCTACATAAAATACATCC AGTTTCATTGCTTTAGTTACATTTTCA 149 13-5
D13Mit78 67.21 ACAGCACGGGTTTATCATCC TATGCCTGCCAGGCTTCTAT 229 13-6
D14Mit179 4.92 CCACTTGCAGCATTGACAAT CAAACATCTGTGACAATAAAATTTCA 144 14-1P
D14Mit126 11.94 CCTGTCCCACAACACCTTTT TATACATATGGGTAGCACTGAGTGG 140 14-2
D14Mit60 24.6 AGGCTGCCCATAAAAGGG GTTTGTGCTAATGTTCTCATCTGG 132 14-3
D14Mit259 27.65 TGGTGTCTCCTTCGGAATTT TAAATGTAAAAGGTAAAGGCAATGG 125 14-259
D14Mit39 35.69 AAAGAGCAACCCCCAATTCT ACTTTTACCTGGTCTCCAAAAGC 246 14-39
D14Mit68 37.61 GTGGCATGCACAACCGTATA CCCTTTTGAGGTGCTTGTTT 153 14-4
D14Mit194 45.96 AATATTCTAAATGAAATCCAATGTGTG TTAATTGCAAGTAACACAATGAGTAGG 92 14-4B
D14Mit95 57.2 TATTTTTAAGTCAGTATACACATGCGC TTATCCAAGTGTATTTAAAGAAGAGGC 124 14-5
D14Mit97 62.2 TCAGTCCAAACTCTGTTAATCTTCC CAGCTCCACATTTTTGCTCA 136 14-6A
D15Mit13 1.84 GGAGACAAAAATGAACTCCTGG TTGTAAGACAAGCATAGCTCAACA 136 15-13
D15Mit265 6.08 ACATTAGTCAACTATGCTGGTACTCTG TTCCTCTCTAATGTCAATTGTTTCA 198 15-265
D15Mit138 15.68 TTCAATTCCCTTTTGTCAAATG CAAGACCCTAGATTCAGTCTACCC 147 15-138
D15Mit154 16.82 AGCACTGGGTACACAAACTGG ATGAAAGCATGTGTAGTCTTTCTCA 150 15-2
D15Mit128 25.58 CAAGTTCTGCAAAGAATTATTTATGC CCACTTTGAAGTTTTCTTTCTTAGC 134 15-3
D15Mit92 32.19 AGTCTCTCTCCCCCTTCTCTC TGCCACAAGCACAATAGTATCC 147 15-3B
D15Mit80 38.02 CATTGAGGGTTTGTAGGTTGG ACCCCTGCAAGTTGTCTTTG 149 15-4
D15Mit34 45.31 TGGACAACCATTTTGGACAA CTTTCTGTCAGGCATCACCA 147 15-34
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Table 2: Continued.
Marker cM Primer F Primer R Product size Lab code
D15Mit244 48.65 TCTACCCTCTGTGGAACATCG CTTTGTGTCCATACACTAATATCAAGG 116 15-4P
D15Mit16 58.05 AGACTCAGAGGGCAAAATAAAGC TCGGCTTTTGTCTGTCTGTC 119 15-6
D16Mit131 3.41 TGGTGGTGGTGTTGATGGTA AAGACCATTTCTAATAAACAACACCC 140 16-1
D16Mit136 27.82 AGATAATTCCCGTGAGAATAAAACC TTGAGAAGTTTGCCCTATAATGG 129 16-2
D16Mit30 33.01 GTGCACATACATACCACAGCG TCACTGCAGGGAGGTTCAG 152 16-30
D16Mit64 34.22 TACCATGATCAGTCCAAAGGC ACTTAAGGTTGTCCTGTGGGG 220 16-3
D16Mit140 40.3 ATAGTTGAAAAACTTGAACATGCG GAAAAGGTTAATGCTGGTCACC 145 16-3B
D16Mit19 45.36 CAGGCATGTGAACAAAGTGG GTGACTGATGAATGCCTGACA 121 16-3C
D16Mit70 48.81 GGATCTATATGCTATAGAACCATTCA GTCATCAATTCCATTTCCTAATATAGA 187 16-4
D16Mit71 57.06 TAGAAAATCTTCAAATAGGATCTGTTC GAGCATTTCCCTTTTACCTGG 154 16-6A
D17Mit164 2.11 AGGCCCTAACATGTAGCAGG TATTATTGAGACTGTGGTTGTTGTTG 133 17-1
D17Mit133 12.53 TCTGCTGTGTTCACAGGTGA GCCCCTGCTAGATCTGACAG 188 17-1C
D17Mit51 19.74 TCTGCCCTGTAACAGGAGCT CTTCTGGAATCAGAGGATCCC 154 17-2
D17Mit68 23.55 GTCCTGACATCATGCTTTGTG CTACCGTTTGGAAGGCTGAG 130 17-68
D17Mit20 29.73 AGAACAGGACACCGGACATC TCATAAGTAGGCACACCAATGC 165 17-3
D17Mit205 39.3 TGTGCATGTATATGTGTGTGAATG GCTAAGTCAGAAGAGTTCTGTAATGG 223 17-4
D17Mit1002 50.97 TCTGAATGCTGACTTCCATCC ACACATATGTGTAGTGTATGAATGTGC 138 17-4P
D17Mit123 60.67 CACAAGGAGGGAGCCTGTAG CACCGTAAGAGTCTAATAATAAGGGG 133 17-6
D18Mit222 8.08 AATCCAAGATTGACATGTGGC CTTAGATGCCCTGTCTTAAAAAAA 113 18-1
D18Mit226 18.18 CAGGCAGGGTGCATATATTATAA TATCTGTTTATGTGTGTACATTGTGTG 125 18-1C
D18Mit177 21.39 CTGTAGTTTATCAGTTCACCCTGTG TGTGCTGTTAAACAAATATCTCTGG 171 18-2
D18Mit91 29.67 TCCACAAATGTTGGCAAAGA TTTCTGGCCATATTGGAAGC 140 18-3
D18Mit124 32.15 CCCAAATGGGGTGTCTTTTA CTGCCACACATTTGTGTGTATG 150 18-4
D18Mit184 39.7 CACACATGTGTAGGTAGGTAGGTAGG CGCACAAGGACTACTGAAACA 172 18-4C
D18Mit186 45.63 AAGTGTTGGGCAAAGGCTAA CTTTAGTATAGTGTGCATGAGTGTGA 125 18-5
D18Mit7 51.92 ACAGGAGAACGGGAACTCAG GCCAGAGTGGACCAAGATGA 95 18-5B
D18Mit129 53.28 CCAGCACAGAGGCAGTCAT TGATTCTTGGGTCCTGAATACA 138 18-5C
D19Mit68 3.38 CCAATACAAATCAGACTCAATAGTCG AGGGTCTCCCCATCTTCCTA 132 19-1
D19Mit60 13.9 CAACACCTCACTGTTTAGGAACC GCTGAGGTCAATATTTAGCATGC 136 19-60
D19Mit45 16.14 CCATTCATAAAATGGGCTTAGG ACCATGAATGTGTTTTGAGGTG 145 19-2A
D19Mit30 21.34 GGTGGCTTAGAAATAGTATCGAAA CCAGCTCTAGGCAGGCATAT 150 19-2B
D19Mit88 32.23 AACAGTGCAACTTTGGAGGC TCATTGGAACTGTCTTAACAGTGC 148 19-3
D19Mit19 34.08 CCTGTGTCCATACAGGCTCA ACCATATCAGGAAGCACCATG 138 19-19
D19Mit11 36.26 TCAAAGTCAAGGTGGGCAG ACTTTCCAGATGTTGGGCAC 146 19-4
D19Mit1 50.32 AATCCTTGTTCACTCTATCAAGGC CATGAAGAGTCCAGTAGAAACCTC 122 19-5
D19Mit71 56.28 ATGATTCCCGCAGTTTTGTC TCTCAACTGTTATTCCTCAATAGCC 136 19-6
DXMit136 4.23 ACGGAAACACTCTTATGTGCG ATTTTGATTACAGCATGTCCCC 182 X-136
DXMit48 25.51 ACCTCCCCCTGCATTACTCT TTCTCCAGAATCCATGCTCC 105 X-48
DXMit62 34.6 GCAATTGTGATGTTGTAGTAAATATGG ATAACTGAGGTCTGCGGGG 125 X-62
DXMit110 35.53 TGACATGAAGTATGTGTTCCTGC TAGGCACATGTTCACATGGG 135 X-110
DXMit170 45.87 TGCAGGCACTAACAGTGAGG TAGTTTCACTGTGCCATTGTATACA 115 X-170
DXMit179 53.17 TTTGATAGAGCCATGTTTGGC CAGGCTAGCCTCAAACTCTCA 122 73.26
DXMit79 68.46 AGTCTGCCTTCTCTTTCTGTATCC TGAAACTATTCCAACATTATTCTTGG 138 53.17
DXMit153 73.26 CAATCAAGCAGATGGAAGCA AAGGACTGCCAAGAGGACAA 143 68.46
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Table 3: The markers that yielded PCR bands but could not be included in the panel due to their not meeting the set criteria.
(a) Category 1: markers that yielded the same size bands in all the strains
Marker cM Primer F Primer R Lab code
D2Mit74 103.43 CCAAGCTTGCAGTTTGTTAGC AGGTGTTATTGAGCCCTGTATAGC 2-6A
D10Mit88 28.64 AAGATGAGAAGATAACATGTCAGGC TTCTGAATTAAGTTCATCTGAACCC 10-2C
D11Mit226 5.64 AGGTGAACTCTTTTGAAGTTTGTG AAAGGAGTGACTGAGAAAGACACC 11-1
D11Mit60 42.86 AGAGAGGCAAAAATTCCAAGC CTTCCTGATGGTAGGATTTAGGC 11-60
D16Mit51 53.78 CCTCAGGTCAGTCAGGATTTAA CCTGTTCACCCTCTCCACAT 16-5
DXMit57 16.24 AGTAGCAAGTAGACTCTCAAAGAGGG TCTGGCATACATGGGCACT X-57
DXMit81 20.59 GAGGAGCATCAACCTTCTCG GAGGTGGGGAGAAACAGAGG X-81
DXMit63 41.51 TTATAAATTAGTGTTACCACATGCAGC AACATTTTTTTCCTAGCATGTGTG X-63
DXMit186 76.75 ATCAATGCATAGTATTTGGGCC AATTTGTCACTGCGGGTAGG X-186
(b) Category 2: markers that failed to amplify a PCR band in some strains
Marker cM Primer F Primer R Lab code
D1Mit375 23.18 TAAATCCATAGATGATAGATCAGTGTG GTGGAAAAAAAACCTAAGACACC 1-2C
D1Mit76 33.31 ACAAAGGAAACTAAACAGACTCGG CTCCCTCAAATACATCTTTGGC 1-3C
D1Mit308 50.78 GAGGCTATGAGTCAAATGGACC TTTATGAGGTGCTGAGATGCA 1-5
D2Mit448 65.66 TACTGTTTGCATTTGAGTGCG AAAAAGTAATGGTTGGGGCC 2-4B
D3Mit278 32.59 TCTAATATTGGAAAATGAATTTCTCTC TATGCCCACATGCACACC 3-3P
D5Mit309 42.22 TAGAGCCTATTTCAAACCCCC GTTGCATCCATAGCAAGCAA 5-4
D10Mit49 1.91 GGAATTTACACTGGAATACAACCC GTGGGCATTTGCACTGTG 10-1
D11Mit168 78.74 CAGGGATTTGACTTTTAACCTCC GAAATGGCTCCTACAACCTCC 11-168
D14Mit132 6.03 GAACAGCACCATCCACACAC GTGGGGTTATATGCAGATACTCG 14-1
D15Mit147 46.85 GATGTGTGAAAAATTTTGTTTCTTG GTCTCAAAGGAATAAGAAAGAGATGG 15-5
D17Mit3 34.9 GATCTTTTCTTATTCTGGTT GCAAAGTCATGTACTCTGAG 17-3B
D17Mit39 45.64 CCTCTGAGGAGTAACCAAGCC CACAGAGTTCTACCTCCAACCC 17-5
D18Mit48 51.89 TTGCACTCACAGGGCACAT TCAGAGTTTCCAGAAGACACCA 18-6
D18Mit25 59.05 CTGGAAATAAAACCTGGGCA TTTAGCCTAACTGAGTTCCAGACC 18-7
D19Mit31 8.84 CAATACAGAGTAATGATTGCCTGA TTCACATTTTGGGATGCTCA 19-1B
D19Mit41 13.18 AGCCCTCCACCCAGTTTC TCTGGGGAAAAAGGATGAGA 19-2
DXMit124a 4.25 AAGGAGAAGTAGAAGAAAGAAAAGAGG GGTGTAGCCTCAAAAAAGATGG X-124a
DXMit68 29.49 TCCTTTGGCCTCCTGCATAT TGTTCTTACAATGAGCCTCATAGG X-68
DXMit114 42.82 ATGGCATCCACAGTACCACA GTAAAATCAATTTGTGAATAAGGAAGC X-114
DXMit95 45.86 CTGTCAATCTAATTCTCTATGTCTGTG CTTTCCTGGGTGGCAGTG X-95
DXMit155 67.49 TGTGCACCACCACCATTC AGGATCTGAGTGCCCAACC X-155
(c) Category 3: markers that amplified multiple PCR products in most (or all) strains
Marker cM Primer F Primer R Lab code
D11Mit86 32.13 TTGACATTGTGACAAAGACTTTCA AAGGCATCATGAGGTTTTTAGTG 11-3
D12Mit118 44.93 CATCTTCAATAAAATGGAGATGTACA CGCTTTCCCTTCATGTACTAGC 12-4
D13Mit107 50.2 CAACTGAGCCACATTCCTAGC CAGCCACAGGATGATGAGG 13-4
DXMit98 72.38 GAGAGCAGGACTATGACTTG ACACACCAGTTCGCACACAT X-98
DXMit222 78.31 TTGGTTTGGGGTTTTTTTTG ATTCCTGATAATGTCTTCTGGACA X-222
not yield a reliable PCR product in most/all of the strains)
might have not worked due to technical errors that may have
occurred during some steps like primer synthesis or primer
reconstitution; we do not rule out the possibility that some
of these primers may yield PCR products if they are resyn-
thesized. The markers that did not meet our criteria because
of the above reasons are listed in Table 3 and Supplementary
Table S1: providing the list of primers and markers that failed
in our hands will help researchers to compare the results if
they intend to test more markers to expand the streamlined
panel presented here.
There is some debate about the minimum number of
markers needed per chromosome for identifying the regions
between the donor and recipient strains [32]. A study con-
cluded that as few as three markers per chromosome were
sufficient to achieve similarly meaningful results as that of
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over 6 markers per chromosome [33]. Computer simulation
[20] indicated that a relatively modest selection effort of 60
evenly spacedmarkers with 25 cM spacing (corresponding to
3 markers per chromosome), 16 males per generation, would
typically reduce unlinked donor genome contamination to
below 1% by four backcross generations (N5). We conclude
that the list presented here can serve to choose panels of
markers for most two-strain combinations with at least 3
to 4 markers per chromosome (with exception of a very
few combinations). Further studies that compare smaller and
larger panels ofmarkers in the same set of samples formarker
assisted speed congenics are needed to address this question
unequivocally.
In recent years there have been advancements in the
approaches used for speed congenics.These methods include
(i) use of fluorescently labeled primers to amplify SSLPmark-
ers followed by resolving the products in sequencing gels
[29] and (ii) microarray chips of SNPs [29, 34–36]. With the
advent of newer methods particularly those that use SNP
based marker analysis, a very high number of markers per
chromosome can be screened simultaneously that increases
the resolution severalfold compared to the conventional SSLP
based markers analysis. Although there are some computer
simulation studies for assessing the efficiency of speed con-
genic screening in general [32] and algorithm based reports
to compare SNP and SSLP based speed congenic screens [37]
there are no systematic studies to compare the two methods
to assess the efficiency and cost effectiveness of each method.
Here, we compare the SNP and SSLP based approaches in
terms of their adoptability and feasibility to most laboratory
settings including their cost. The hands-on-time in perform-
ing gel based assays has been reduced greatly by newer
methods that use SNP arrays. However these methods have
some limitations compared to traditional agarose gel elec-
trophoresis (AGE) based SSLPmarker analysis. (1)The newer
methods are expensive in terms of the initial investment in
reagents and/or operational costs compared to SSLP-AGE
method.On the contrary, basic requirements needed forAGE
based systems are readily available in any molecular biology
laboratory and the only additional investment needed will
be to synthesize the required oligonucleotides. (2) Subset of
markers to be analyzed in the subsequent generations cannot
be skipped from the panel unlike in the AGE based method
where the number of markers to be analyzed will become
significantly reduced in successive generations and so also the
overall cost of the assay. Other advantages of AGE based SSLP
marker analysis over these newer methods are as follows: (i)
the equipment needed to perform the assay is readily available
in most laboratories and (ii) it can be routinely performed by
many researchers and technicians without the need of special
training as needed for SNP based approaches.
Considering the highest resolution that is possible with
the SNP based method, it can be regarded as the superior
method of all. However, the microchips that are currently
available are expensive and the cost for analyzing eachmouse
DNA sample runs to about US $100 to $150. Assuming that
about 15 mouse DNA samples per generation for 5 genera-
tions are analyzed, a typical speed congenic project would
cost about $15,000 to $22,500. On the other hand, when using
SSLP-AGE approach, since marker analysis is done manually,
the markers that were fixed in the previous generation can
be skipped in the successive generations; this makes the
SSLP-AGE based method cost effective compared to SNP
based method. It is estimated that a typical SSLP based
speed congenic screen that employs analysis of 15 samples
per generation for 5 generations using 5 markers per chro-
mosome would need about 2000 to 2300 PCR reactions. At
the rate of $2 to $2.5 per reaction (cost analysis done in our
laboratory) it will cost about $4000 to $5750 for one full speed
congenic project. Furthermore, SSLP-AGE method can be
performed in any simple molecular biology labs compared to
SNP method that requires expensive equipment.
4. Conclusions
Although some information about microsatellite marker
differences between the commonly used inbredmouse strains
was available, there was no systematic study to validate a
large panel of markers for SSLP-AGE based speed congenic
screening. The panel of marker sets validated and presented
in this study serves as a ready reference for researchers who
wish to perform cost-effective speed congenic screening in a
pair of strains from the panel. The assay can be performed in
any standard molecular biology lab. The data in this
report is available at ftp://ftp.informatics.jax.org/pub/datasets/
index.html#Guru.
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